Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023
- PMID: 38705359
- DOI: 10.1016/j.ajcnut.2024.04.029
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023
Abstract
The rapidly evolving field of immunometabolism explores how changes in local immune environments may affect key metabolic and cellular processes, including that of adipose tissue. Importantly, these changes may contribute to low-grade systemic inflammation. In turn, chronic low-grade inflammation affecting adipose tissue may exacerbate the outcome of metabolic diseases. Novel advances in our understanding of immunometabolic processes may critically lead to interventions to reduce disease severity and progression. An important example in this regard relates to obesity, which has a multifaceted effect on immunity, activating the proinflammatory pathways such as the inflammasome and disrupting cellular homeostasis. This multifaceted effect of obesity can be investigated through study of downstream conditions using cellular and systemic investigative techniques. To further explore this field, the National Institutes of Health P30 Nutrition Obesity Research Center at Harvard, in partnership with Harvard Medical School, assembled experts to present at its 24th Annual Symposium entitled "Adiposity, Immunity, and Inflammation: Interrelationships in Health and Disease" on 7 June, 2023. This manuscript seeks to synthesize and present key findings from the symposium, highlighting new research and novel disease-specific advances in the field. Better understanding the interaction between metabolism and immunity offers promising preventative and treatment therapies for obesity-related immunometabolic diseases.
Keywords: diet; immunity; immunometabolism; inflammation; obesity.
Copyright © 2024 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The role of adipose tissue immune cells in obesity and low-grade inflammation.J Endocrinol. 2014 Sep;222(3):R113-27. doi: 10.1530/JOE-14-0283. Epub 2014 Jul 8. J Endocrinol. 2014. PMID: 25006217 Review.
-
Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity.Front Immunol. 2018 Feb 9;9:169. doi: 10.3389/fimmu.2018.00169. eCollection 2018. Front Immunol. 2018. PMID: 29479350 Free PMC article. Review.
-
Effects of Obesity-Associated Chronic Inflammation on Peripheral Blood Immunophenotype Are Not Mediated by TNF in Female C57BL/6J Mice.Immunohorizons. 2021 Jun 4;5(6):370-383. doi: 10.4049/immunohorizons.2100038. Immunohorizons. 2021. PMID: 34088851
-
T Cells in Adipose Tissue: Critical Players in Immunometabolism.Front Immunol. 2018 Oct 30;9:2509. doi: 10.3389/fimmu.2018.02509. eCollection 2018. Front Immunol. 2018. PMID: 30459770 Free PMC article. Review.
-
Obesity associated disease risk: the role of inherent differences and location of adipose depots.Horm Mol Biol Clin Investig. 2018 Mar 16;33(2):/j/hmbci.2018.33.issue-2/hmbci-2018-0012/hmbci-2018-0012.xml. doi: 10.1515/hmbci-2018-0012. Horm Mol Biol Clin Investig. 2018. PMID: 29547393 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical